{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:45:41Z","timestamp":1791049541322,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11845-021-02855-1","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:04:12Z","timestamp":1642464252000},"page":"2743-2750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genotype\u2013phenotype correlations in alpha-sarcoglycanopathy: a systematic review"],"prefix":"10.1007","volume":"191","author":[{"given":"Luke","family":"Carson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Merrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"2855_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/345315a0","volume":"345","author":"JM Ervasti","year":"1990","unstructured":"Ervasti JM, Ohlendieck K, Kahl SD et al (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345:315\u2013319. https:\/\/doi.org\/10.1038\/345315a0","journal-title":"Nature"},{"key":"2855_CR2","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","volume":"90","author":"BJ Petrof","year":"1993","unstructured":"Petrof BJ, Shrager JB, Stedman HH et al (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 90:3710\u20133714. https:\/\/doi.org\/10.1073\/pnas.90.8.3710","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2855_CR3","doi-asserted-by":"publisher","unstructured":"Eid Mutlak Y, Aweida D, Volodin A et al (2020) A signaling hub of insulin receptor, dystrophin glycoprotein complex and plakoglobin regulates muscle size. Nat Commun 11.\u00a0https:\/\/doi.org\/10.1038\/s41467-020-14895-9","DOI":"10.1038\/s41467-020-14895-9"},{"key":"2855_CR4","doi-asserted-by":"publisher","first-page":"23739","DOI":"10.1016\/s0021-9258(20)80440-2","volume":"268","author":"SL Roberds","year":"1993","unstructured":"Roberds SL, Anderson RD, Ibraghimov-Beskrovnaya O, Campbell KP (1993) Primary structure and muscle-specific expression of the 50-kDa dystrophin- associated glycoprotein (adhalin). J Biol Chem 268:23739\u201323742. https:\/\/doi.org\/10.1016\/s0021-9258(20)80440-2","journal-title":"J Biol Chem"},{"key":"2855_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/ng1195-257","volume":"11","author":"LE Lim","year":"1995","unstructured":"Lim LE, Duclos F, Broux O et al (1995) \u03b2\u2013sarcoglycan: characterization and role in limb\u2013girdle muscular dystrophy linked to 4q12. Nat Genet 11:257\u2013265. https:\/\/doi.org\/10.1038\/ng1195-257","journal-title":"Nat Genet"},{"key":"2855_CR6","doi-asserted-by":"publisher","unstructured":"Noguchi S, McNally EM, Othmane KB et al (1995) Mutations in the dystrophin-associated protein \u03b3-sarcoglycan in chromosome 13 muscular dystrophy. Science (80- ) 270:819\u2013822. https:\/\/doi.org\/10.1126\/science.270.5237.819","DOI":"10.1126\/science.270.5237.819"},{"key":"2855_CR7","doi-asserted-by":"publisher","first-page":"27989","DOI":"10.1074\/jbc.274.39.27989","volume":"274","author":"V Straub","year":"1999","unstructured":"Straub V, Ettinger AJ, Durbeej M et al (1999) \u03b5-Sarcoglycan replaces \u03b1-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex. J Biol Chem 274:27989\u201327996. https:\/\/doi.org\/10.1074\/jbc.274.39.27989","journal-title":"J Biol Chem"},{"key":"2855_CR8","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.1073\/pnas.91.21.9690","volume":"91","author":"EM Mcnally","year":"1994","unstructured":"Mcnally EM, Yoshida M, Mizuno Y et al (1994) Human adhalin is alternatively spliced and the gene is located on chromosome 17q21. Proc Natl Acad Sci U S A 91:9690\u20139694. https:\/\/doi.org\/10.1073\/pnas.91.21.9690","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2855_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/0092-8674(94)90527-4","volume":"78","author":"SL Roberds","year":"1994","unstructured":"Roberds SL, Leturcq F, Allamand V et al (1994) Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 78:625\u2013633. https:\/\/doi.org\/10.1016\/0092-8674(94)90527-4","journal-title":"Cell"},{"key":"2855_CR10","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/hmg\/5.8.1179","volume":"5","author":"V Nigro","year":"1996","unstructured":"Nigro V, Piluso G, Belsito A et al (1996) Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum Mol Genet 5:1179\u20131186. https:\/\/doi.org\/10.1093\/hmg\/5.8.1179","journal-title":"Hum Mol Genet"},{"key":"2855_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0960-8966(00)00174-7","volume":"11","author":"L Politano","year":"2001","unstructured":"Politano L, Nigro V, Passamano L et al (2001) Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord 11:178\u2013185. https:\/\/doi.org\/10.1016\/S0960-8966(00)00174-7","journal-title":"Neuromuscul Disord"},{"key":"2855_CR12","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1212\/WNL.48.5.1227","volume":"48","author":"B Eymard","year":"1997","unstructured":"Eymard B, Romero NB, Leturcq F et al (1997) Primary adhalinopathy (\u03b1-sarcoglycanopathy): Clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology 48:1227\u20131234. https:\/\/doi.org\/10.1212\/WNL.48.5.1227","journal-title":"Neurology"},{"key":"2855_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/wnl.52.1.176","volume":"52","author":"C Angelini","year":"1999","unstructured":"Angelini C, Fanin M, Freda MP et al (1999) The clinical spectrum of sarcoglycanopathies. Neurology 52:176\u2013179. https:\/\/doi.org\/10.1212\/wnl.52.1.176","journal-title":"Neurology"},{"key":"2855_CR14","doi-asserted-by":"crossref","unstructured":"Sandon\u00e0 D, Betto R (2009) Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects. Expert Rev Mol Med 11","DOI":"10.1017\/S1462399409001203"},{"key":"2855_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13023-019-1021-9","volume":"14","author":"Z Xie","year":"2019","unstructured":"Xie Z, Hou Y, Yu M et al (2019) Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients. Orphanet J Rare Dis 14:43. https:\/\/doi.org\/10.1186\/s13023-019-1021-9","journal-title":"Orphanet J Rare Dis"},{"key":"2855_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/ejhg.2008.9","volume":"16","author":"M Trabelsi","year":"2008","unstructured":"Trabelsi M, Kavian N, Daoud F et al (2008) Revised spectrum of mutations in sarcoglycanopathies. Eur J Hum Genet 16:793\u2013803. https:\/\/doi.org\/10.1038\/ejhg.2008.9","journal-title":"Eur J Hum Genet"},{"key":"2855_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/jmg.34.6.470","volume":"34","author":"A Carri\u00e9","year":"1997","unstructured":"Carri\u00e9 A, Piccolo F, Leturcq F et al (1997) Mutational diversity and hot spots in the \u03b1-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J Med Genet 34:470\u2013475. https:\/\/doi.org\/10.1136\/jmg.34.6.470","journal-title":"J Med Genet"},{"key":"2855_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/ng0695-243","volume":"10","author":"F Piccolo","year":"1995","unstructured":"Piccolo F, Roberds SL, Jeanpierre M et al (1995) Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet 10:243\u2013245. https:\/\/doi.org\/10.1038\/ng0695-243","journal-title":"Nat Genet"},{"key":"2855_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0165-3806(95)00169-7","volume":"91","author":"M Mora","year":"1996","unstructured":"Mora M, Di Blasi C, Barresi R et al (1996) Developmental expression of dystrophin, dystrophin-associated glycoproteins and other membrane cytoskeletal proteins in human skeletal and heart muscle. Dev Brain Res 91:70\u201382. https:\/\/doi.org\/10.1016\/0165-3806(95)00169-7","journal-title":"Dev Brain Res"},{"key":"2855_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2353\/ajpath.2008.071146","volume":"173","author":"S Gastaldello","year":"2008","unstructured":"Gastaldello S, D\u2019Angelo S, Franzoso S et al (2008) Inhibition of proteasome activity promotes the correct localization of disease-causing \u03b1-sarcoglycan mutants in HEK-293 cells constitutively expressing \u03b2-, \u03b3-, and \u03b4-sarcoglycan. Am J Pathol 173:170\u2013181. https:\/\/doi.org\/10.2353\/ajpath.2008.071146","journal-title":"Am J Pathol"},{"key":"2855_CR21","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.4161\/cc.6.10.4182","volume":"6","author":"G Bonuccelli","year":"2007","unstructured":"Bonuccelli G, Sotgia F, Capozza F et al (2007) Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice. Cell Cycle 6:1242\u20131248. https:\/\/doi.org\/10.4161\/cc.6.10.4182","journal-title":"Cell Cycle"},{"key":"2855_CR22","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1093\/hmg\/ddn029","volume":"17","author":"M Bartoli","year":"2008","unstructured":"Bartoli M, Gicquel E, Barrault L et al (2008) Mannosidase I inhibition rescues the human \u03b1-sarcoglycan R77C recurrent mutation. Hum Mol Genet 17:1214\u20131221. https:\/\/doi.org\/10.1093\/hmg\/ddn029","journal-title":"Hum Mol Genet"},{"key":"2855_CR23","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1093\/hmg\/ddu088","volume":"23","author":"E Bianchini","year":"2014","unstructured":"Bianchini E, Fanin M, Mamchaoui K et al (2014) Unveiling the degradative route of the V247M a-sarcoglycan mutant responsible for LGMD-2D. Hum Mol Genet 23:3746\u20133758. https:\/\/doi.org\/10.1093\/hmg\/ddu088","journal-title":"Hum Mol Genet"},{"key":"2855_CR24","doi-asserted-by":"publisher","unstructured":"Hoch L, Henriques SF, Bruge C et al (2019) Identification of thiostrepton as a pharmacological approach to rescue misfolded alpha-sarcoglycan mutant proteins from degradation. Sci Rep 9.\u00a0https:\/\/doi.org\/10.1038\/s41598-019-43399-w","DOI":"10.1038\/s41598-019-43399-w"},{"key":"2855_CR25","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/hmg\/ddy013","volume":"27","author":"M Carotti","year":"2018","unstructured":"Carotti M, Marsolier J, Soardi M et al (2018) Repairing folding-defective \u03b1-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D. Hum Mol Genet 27:969\u2013984. https:\/\/doi.org\/10.1093\/hmg\/ddy013","journal-title":"Hum Mol Genet"},{"key":"2855_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/humu.21659","volume":"33","author":"T Soheili","year":"2012","unstructured":"Soheili T, Gicquel E, Poupiot J et al (2012) Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum quality control is associated with minimal structural modifications. Hum Mutat 33:429\u2013439. https:\/\/doi.org\/10.1002\/humu.21659","journal-title":"Hum Mutat"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02855-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-021-02855-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02855-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T08:15:55Z","timestamp":1668672955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-021-02855-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2855"],"URL":"https:\/\/doi.org\/10.1007\/s11845-021-02855-1","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"18 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}